Gad zeevi biography of alberta
•
Published in final edited form as: J Heart Lung Transplant. 2009 Mar;28(3):10.1016/j.healun.2008.12.017. doi: 10.1016/j.healun.2008.12.017
A consensus conference took place on April 8, 2008 to assess the current status of sensitization in the pre–heart transplant patient, the use and efficacy of desensitization therapies, and the outcome of desensitized patients after heart transplantation. The conference had 71 participants (transplant cardiologists, surgeons, immunologists and pathologists; see Appendix) representing 51 heart transplant centers from North America, Europe, Asia and Australia. Prior to the conference, survey data (regarding the sensitized patient) were submitted by 23 of the 51 centers participating in the conference (Table 1).
Table 1. Sensitization Consensus Conference Survey Results (April 8, 2008)a.
Assays used by surveyed centers to detect circulating antibodies:
|